India Foot and Ankle Allogarft

India Foot and Ankle Allogarft

The foot and ankle allograft market is a part of the orthopedic industry that utilizes donated human tissue for the treatment of foot and ankle injuries and conditions. Foot and ankle allografts are used to replace damaged or injured tissue, such as ligaments, tendons, and bone, and they can be used to treat a variety of conditions, including arthritis, fractures, and tendonitis. The foot and ankle allograft market is driven by a number of factors, including the growing incidence of foot and ankle injuries and conditions, the aging population, and the increasing use of minimally invasive surgical techniques. It is observed that injury rates among young athletes have significantly increased during the last 10–15 years. For instance, football and cricket players are suffering 500% more knee and ankle injuries. Whereas 400% more people are suffering from anterior cruciate ligament (ACL) injuries.

The India Foot and Ankle Allograft market was valued USD XX Million in the year 2022 and is expected to grow with a CAGR of 9% during the forecasted period (2022-2030). Increasing cases of allograft procedures that include some growth factors such as joint implants, trauma & hairline fractures, rheumatoid arthritis & osteoarthritis, diabetic foot diseases, ligament injuries, neurological disorders, hammertoe, osteochondral grafts, osseous/structural graphs, and plastic surgery are propelling the foot and ankle allograft market.

The India Foot and Ankle Allograft Market is expected to grow at a strong CAGR of ~9% during the forecast period.

• Based on product, the foot and ankle allograft market is segmented into allograft wedges, allograft tendons, allograft acellular dermal matrix, cartilage allograft matrix, skin allografts, and amniotic membranes. In 2022, the allograft tendons category is anticipated to witness a significant growth rate during the forecast period. The growth of this category is mainly due to the increasing cases of fractures, rheumatoid arthritis & osteoarthritis, diabetic foot diseases, and repair of limbs. For Instance, According to National Institutes of Health published data, every year, 100,000 legs are amputated in India due to diabetes/diabetic foot ulcers, and the numbers are only increasing.
• Based on end-user, the foot and ankle allograft market is categorized into hospitals, ambulatory surgery centers, orthopedic clinics, and rehabilitation centers. The hospitals and clinics category dominated the foot and ankle allograft market and is expected to grow significantly in the forecast period. The number of patients with conditions such as rheumatoid arthritis, ligament injuries, foot ulcers, osteoarthritis, and the availability of skilled professionals and surgical equipment in hospitals are some factors driving the growth of this category. In addition, more than 90% of people with rheumatoid arthritis (RA) develop symptoms in the foot and ankle-related disease. Furthermore, according to the National Institutes of Health (NIH), Out of every 100,000 people, 71 are diagnosed with rheumatoid arthritis every year. About 1.5 million Americans have rheumatoid arthritis.
• Some of the major players operating in the market include Stryker Corporation, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Arthrex Inc., Össur hf., Integra LifeSciences, CONMED Corporation, DePuy Synthes, RTI Surgicals, Acumed LLC, among others., among others.